About MPD-RC
The Myeloproliferative Disorders Research Consortium (MPD-RC) is an international, multi-institutional non profit consortium funded by the National Cancer Institute and set up to coordinate, facilitate, and perform basic and clinical research investigating the genetic and cellular mechanisms of the Philadelphia Chromosome (Ph) negative myelo-proliferative disorders (MPD).
The ultimate goal is to develop novel therapeutic strategies to improve the management of patients with this type of diseases. More »
Info for Patients
Find patient support group and share your experience with other patients and their family. More »
Clinical Trials

We are now recruiting patients for Trials 101, 103, 104, 105, 106, 107.


